FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366997816> ?p ?o ?g. }

• W4366997816 abstract "The clinical benefits and risks of anticoagulation therapy in patients with chronic kidney disease (CKD) are still inconclusive. We describe the outcomes of patients with atrial fibrillation (AF) after anticoagulation therapy according to differences in creatinine clearance (CrCl). We also aimed to determine the patients who could benefit from anticoagulation therapy.This is a retrospective observational review of patients with AF who were managed at Asan Medical Center (Seoul, Korea) between January 1, 2006, and December 31, 2018. Patients were categorized into groups according to their baseline CrCl by Cockcroft-Gault equation and their outcomes were evaluated (CKD 1, ≥ 90 mL/min; CKD2, 60-89 mL/min; CKD3, 30-59 mL/min; CKD4, 15-29 mL/min; CKD 5, < 15 mL/min). The primary outcome was NACE (net adverse clinical events), defined as a composite of all-cause mortality, thromboembolic events, and major bleeding.We identified 12,714 consecutive patients with AF (mean 64.6 ± 11.9 years, 65.3% male, mean CHA2DS2-VASc score 2.4 ± 1.6 points) between 2006 and 2017. In patients receiving anticoagulation therapy (n = 4447, 35.0%), warfarin (N = 3768, 84.7%) was used more frequently than NOACs (N = 673, 15.3%). There was a higher 3-year rate of NACE with renal function deterioration (14.8%, 18.6%, 30.3%, 44.0%, and 48.8% for CKD stages 1-5, respectively).The clinical benefit of anticoagulation therapy was most prominent in patients with CKD 1 (hazard ratio [HR] 0.49, 95% confidence interval [CI] 0.37-0.67), 2 (HR 0.64 CI 0.54-0.76), and 3 (HR 0.64 CI 0.54-0.76), but not in CKD 4 (HR 0.86, CI 0.57-1.28) and 5 (HR 0.81, CI 0.47-1.40). Among patients with CKD, the benefit of anticoagulation therapy was only evident in those with a high risk of embolism (CHA2DS2-VASc score ≥ 4, HR 0.25, CI 0.08-0.80).Advanced CKD is associated with a higher risk of NACE. The clinical benefit of anticoagulation therapy was reduced with the increasing CKD stage." @default.
• W4366997816 created "2023-04-27" @default.
• W4366997816 creator A5025310836 @default.
• W4366997816 creator A5039057457 @default.
• W4366997816 creator A5041234774 @default.
• W4366997816 creator A5048882088 @default.
• W4366997816 creator A5053371139 @default.
• W4366997816 creator A5080690128 @default.
• W4366997816 date "2023-04-25" @default.
• W4366997816 modified "2023-10-02" @default.
• W4366997816 title "Clinical benefits and risks of anticoagulation therapy according to the degree of chronic kidney disease in patients with atrial fibrillation" @default.
• W4366997816 cites W1978233306 @default.
• W4366997816 cites W1981440884 @default.
• W4366997816 cites W1987884921 @default.
• W4366997816 cites W2018856451 @default.
• W4366997816 cites W2025282593 @default.
• W4366997816 cites W2038866018 @default.
• W4366997816 cites W2054077136 @default.
• W4366997816 cites W2054823150 @default.
• W4366997816 cites W2084427803 @default.
• W4366997816 cites W2100505398 @default.
• W4366997816 cites W2108616699 @default.
• W4366997816 cites W2109814399 @default.
• W4366997816 cites W2114775432 @default.
• W4366997816 cites W2117807413 @default.
• W4366997816 cites W2132505348 @default.
• W4366997816 cites W2137138584 @default.
• W4366997816 cites W2138986942 @default.
• W4366997816 cites W2142859473 @default.
• W4366997816 cites W2147767239 @default.
• W4366997816 cites W2150333966 @default.
• W4366997816 cites W2152412672 @default.
• W4366997816 cites W2156377081 @default.
• W4366997816 cites W2158098319 @default.
• W4366997816 cites W2165868179 @default.
• W4366997816 cites W2442448576 @default.
• W4366997816 cites W2469001618 @default.
• W4366997816 cites W2743120910 @default.
• W4366997816 cites W2748517697 @default.
• W4366997816 cites W2780840915 @default.
• W4366997816 cites W2793790918 @default.
• W4366997816 cites W2989714602 @default.
• W4366997816 cites W3011312705 @default.
• W4366997816 cites W3082188176 @default.
• W4366997816 cites W3113934040 @default.
• W4366997816 cites W3134140487 @default.
• W4366997816 cites W4221003094 @default.
• W4366997816 cites W4293510396 @default.
• W4366997816 cites W4308365855 @default.
• W4366997816 doi "https://doi.org/10.1186/s12872-023-03236-5" @default.
• W4366997816 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37098477" @default.
• W4366997816 hasPublicationYear "2023" @default.
• W4366997816 type Work @default.
• W4366997816 citedByCount "2" @default.
• W4366997816 countsByYear W43669978162023 @default.
• W4366997816 crossrefType "journal-article" @default.
• W4366997816 hasAuthorship W4366997816A5025310836 @default.
• W4366997816 hasAuthorship W4366997816A5039057457 @default.
• W4366997816 hasAuthorship W4366997816A5041234774 @default.
• W4366997816 hasAuthorship W4366997816A5048882088 @default.
• W4366997816 hasAuthorship W4366997816A5053371139 @default.
• W4366997816 hasAuthorship W4366997816A5080690128 @default.
• W4366997816 hasBestOaLocation W43669978161 @default.
• W4366997816 hasConcept C126322002 @default.
• W4366997816 hasConcept C159641895 @default.
• W4366997816 hasConcept C164705383 @default.
• W4366997816 hasConcept C167135981 @default.
• W4366997816 hasConcept C197934379 @default.
• W4366997816 hasConcept C207103383 @default.
• W4366997816 hasConcept C2776301958 @default.
• W4366997816 hasConcept C2778653478 @default.
• W4366997816 hasConcept C2779161974 @default.
• W4366997816 hasConcept C2780306776 @default.
• W4366997816 hasConcept C44249647 @default.
• W4366997816 hasConcept C71924100 @default.
• W4366997816 hasConceptScore W4366997816C126322002 @default.
• W4366997816 hasConceptScore W4366997816C159641895 @default.
• W4366997816 hasConceptScore W4366997816C164705383 @default.
• W4366997816 hasConceptScore W4366997816C167135981 @default.
• W4366997816 hasConceptScore W4366997816C197934379 @default.
• W4366997816 hasConceptScore W4366997816C207103383 @default.
• W4366997816 hasConceptScore W4366997816C2776301958 @default.
• W4366997816 hasConceptScore W4366997816C2778653478 @default.
• W4366997816 hasConceptScore W4366997816C2779161974 @default.
• W4366997816 hasConceptScore W4366997816C2780306776 @default.
• W4366997816 hasConceptScore W4366997816C44249647 @default.
• W4366997816 hasConceptScore W4366997816C71924100 @default.
• W4366997816 hasIssue "1" @default.
• W4366997816 hasLocation W43669978161 @default.
• W4366997816 hasLocation W43669978162 @default.
• W4366997816 hasLocation W43669978163 @default.
• W4366997816 hasOpenAccess W4366997816 @default.
• W4366997816 hasPrimaryLocation W43669978161 @default.
• W4366997816 hasRelatedWork W2042710484 @default.
• W4366997816 hasRelatedWork W2058466993 @default.
• W4366997816 hasRelatedWork W2113389249 @default.
• W4366997816 hasRelatedWork W2118744783 @default.
• W4366997816 hasRelatedWork W2137138584 @default.
• W4366997816 hasRelatedWork W2533192802 @default.
• W4366997816 hasRelatedWork W2560482142 @default.

• next